165 related articles for article (PubMed ID: 2787832)
1. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.
Bergui L; Schena M; Gaidano G; Riva M; Caligaris-Cappio F
J Exp Med; 1989 Aug; 170(2):613-8. PubMed ID: 2787832
[TBL] [Abstract][Full Text] [Related]
2. Circulating malignant precursors in monoclonal gammopathies.
Caligaris-Cappio F; Bergui L; Gaidano GL; Schena M; Putto P; Merico F; Riva M
Eur J Haematol Suppl; 1989; 51():27-9. PubMed ID: 2627991
[TBL] [Abstract][Full Text] [Related]
3. Failure of IL-3 plus IL-6 to induce the proliferation and differentiation of malignant plasma cell precursors from peripheral blood in multiple myeloma.
Tokumine Y; Nishimori Y; Shibayama H; Shibano M; Tagawa S; Machii T; Kitani T
Leukemia; 1993 Feb; 7(2):333-5. PubMed ID: 8426487
[No Abstract] [Full Text] [Related]
4. Tumour necrosis factor-alpha and interleukin 4 promote the differentiation of myeloma cell precursors in multiple myeloma.
Sawamura M; Murakami H; Tamura J; Matsushima T; Sato S; Naruse T; Tsuchiya J
Br J Haematol; 1994 Sep; 88(1):17-23. PubMed ID: 7803239
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 dependence of advanced malignant plasma cell dyscrasias.
Zhang XG; Bataille R; Widjenes J; Klein B
Cancer; 1992 Mar; 69(6):1373-6. PubMed ID: 1540875
[TBL] [Abstract][Full Text] [Related]
6. C-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A
Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
[TBL] [Abstract][Full Text] [Related]
7. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.
Klein B; Zhang XG; Jourdan M; Content J; Houssiau F; Aarden L; Piechaczyk M; Bataille R
Blood; 1989 Feb; 73(2):517-26. PubMed ID: 2783861
[TBL] [Abstract][Full Text] [Related]
8. In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors.
Sonneveld P; Schoester M; de Leeuw K
Br J Haematol; 1991 Dec; 79(4):589-94. PubMed ID: 1772780
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.
Lu ZY; Zhang XG; Rodriguez C; Wijdenes J; Gu ZJ; Morel-Fournier B; Harousseau JL; Bataille R; Rossi JF; Klein B
Blood; 1995 May; 85(9):2521-7. PubMed ID: 7727780
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction between interleukin-6 and interleukin-3 in support of stem cell proliferation in culture.
Ogawa M; Clark SC
Blood Cells; 1988; 14(2-3):329-37. PubMed ID: 3265877
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.
Kawano M; Tanaka H; Ishikawa H; Nobuyoshi M; Iwato K; Asaoku H; Tanabe O; Kuramoto A
Blood; 1989 Jun; 73(8):2145-8. PubMed ID: 2786435
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
13. 'Role of bone marrow stromal cells in the growth of human multiple myeloma.
Caligaris-Cappio F; Bergui L; Gregoretti MG; Gaidano G; Gaboli M; Schena M; Zallone AZ; Marchisio PC
Blood; 1991 Jun; 77(12):2688-93. PubMed ID: 1675130
[TBL] [Abstract][Full Text] [Related]
14. Lack of a role of interleukin 11 in the growth of multiple myeloma.
Paul SR; Barut BA; Bennett F; Cochran MA; Anderson KC
Leuk Res; 1992; 16(3):247-52. PubMed ID: 1532843
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
16. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
17. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
[TBL] [Abstract][Full Text] [Related]
18. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
[TBL] [Abstract][Full Text] [Related]
19. Cytokine network in human multiple myeloma.
Klein B; Bataille R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):273-84. PubMed ID: 1582974
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the in vitro evolution of a myeloma cell line.
Scibienski RJ; Paglieroni T; Caggiano V; Lemongello D; Gumerlock PH; Mackenzie MR
Leukemia; 1992 Sep; 6(9):940-7. PubMed ID: 1518305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
